OVARIAN CANCER: State of the Art
Panama City, 27-29 June 2019



Day 1
Gran Baru
07:30-07:50 Registry (HALL)
07:50-08:00 Welcome remarks
Mauricio Lema & Robert Coleman
08:00-08:40 PARP Inhibitors: The Final Solution?
Chair Mauricio Lema
Speaker Robert Coleman
08:30-08:40 Discussion
08:40-10:00 Baseline Information on Ovarian Cancer
Chair Robert Coleman
08:40-09:00 Genetics for Dummies
Ana Milena Gomez
09:00-09:20 BRCA Testing: Who, What, Where, When, How and Why?
Larissa Meyer
09:20-09:40 Ovarian Cancer Screening
Christina Fotopoulou
09:40-10:00 Discussion
10:00-10:20 Break
10:20-12:00 Pathobiology
Chair Angelica Nogueira
10:20-10:40 Early stage disease – staging and treatment
Reitan Ribeiro
10:40-11:00 Pathogenesis and Prevention
Shannon Westin
11:00-11:20 Clinical Presentation
Larissa Meyer
11:20-11:40 Ovarian Cancer in Developing World
Audrey Tsunoda
11:40-12:00 Discussion
12:00-14:00 LUNCH
14:00-15:30 Primary Interventions 1
Chair Pedro Ramirez
14:00-14:20 Considerations for Primary Surgery
Shannon Westin
14:20-14:40 Role of Imaging in Primary/Recurrent Disease
Nicole Fleming
14:40-15:00 Laparoscopy in Advanced Disease
Anna Fagotti
15:00-15:20 Cytoreductive Surgery Techniques/Outcomes
Reitan Ribeiro
15:20-15:30 Discussion
15:30-15:50 Break
15:50-16:50 Primary interventions 2
Chair Michael Frumovitz
15:50-16:10 Impact of LION Trial
Christina Fotopoulou
16:10-16:30 NACT vs Primary Surgery
Nicole Fleming
16:30-16:40 MISSION Trial:Final Analysis
Anna Fagotti
16:40-16:50 Discussion
16:50-17:10 Break
17:10-18:00 ERAS Pathways in Ovarian Cancer
Chair René Pareja
Speaker Pedro Ramirez
17:40-18:00 Discussion
18:00 Adjourn
Day 2
Gran Baru
08:00-09:30 Adjuvant front-line treatment options
Chair Larissa Meyer
08:00-08:20 Adjuvant Therapy Standard of Care
Carlos Vargas
08:20-08:40 IP Chemo: Raise and Fall
Michael Frumovitz
08:40-09:00 Novel Treat Including: PARPi, Immunotherapy and Angiogenesis
Shannon Westin
09:00-09:20 Role of Immunotherapy in Ovarian Cancer
Robert Coleman
09:20-09:30 Discussion
09:30-09:50 Break
09:50-11:20 HIPEC Real Life Indications
Chair Robert Coleman
09:50-10:10 How does HIPEC Work?
Audrey Tsunoda
10:10-10:30 How to Build a HIPEC Service?
Michele De simone
10:30-10:50 HIPEC Front Line Treatment/Interval
Anna Fagotti
10:50-11:20 Should HIPEC be Used on a Regular Basis?
Round table – All the speakers
11:20-12:10  I Finished Therapy…Now What?
Chair Audrey Tsunoda
11:20 – 11:40 Surveillance After Treatment
Angelica Nogueira
11:40 – 12:00 Patients Reported Outcomes in Clinical Practice
Larissa Meyer
12:00-12:10 Discussion
12:10-14:00 LUNCH
14:00-15:50 Recurrent Disease
Chair Nicole Fleming
14:00-14:20 Options Platinum Sensitive Disease
Carlos Vargas
14:20-14:40 Options in Platinum-Resistant Disease
Mauricio Lema
14:40-15:00 GOG 213: Still We Have to Operate?
Robert Coleman
15:00-15:20 HIPEC Recurrent Disease
Michele De Simone
15:20-15:40 Biomarkers: Current Status and Development
Mauricio Lema
15:40-15:50 Discussion
15:50-16:10 Break
15:50-18:00 Interesting Clinical Situations
Chair Shannon Westin
16:10 – 16:30 Ovarian Pathology, An Update
Anais Malpica
16:30-16:50 Fertility Sparing Options
René Pareja
16:50-17:10 Rare Ovarian Tumors (Mucinous, Small Cell, Carcinosarcoma, Clear Cell)
Michael Frumovitz
17:10-17:30 Sentinel Node Detection in Ovarian Cancer: Current Evidence
Audrey Tsunoda
17:30-17:45 Low Grade Serous
Michael Frumovitz
17:45 Adjourn
Day 3
Gran Baru
08:00-10:00 Just for medical oncologists: Squeezing Robert Coleman
Chair Mauricio Lema
6-8 cases for discussion on medical treatment alternatives
10:00-10:30 Break
10:30-12:30 Just for surgeons
Chair René Pareja
4 video presentations with interactive discussion
Reitán Ribeiro, Audrey Tsunoda, Daniel Sanabria, René Pareja
Chair David Cantú
Round table: Obstacles and Opportunities in Latinamerica for Ovarian Cancer Cytoreductive Surgery
All the attendants
12:30 Closing remarks
René Pareja
Contact us

Send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt